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Previous genetic epidemiological studies of psoriasis
and alopecia areata demonstrated strong heritability
in first-degree relatives and in twins. In recent years,
these two conditions have emerged as two skin
diseases that are starting to yield their secrets through
genome-wide association studies. Both diseases
manifest prominent human leukocyte antigen (HLA)
associations, psoriasis primarily with major histocom-
patibility complex (MHC) Class 1, specifically HLA-Cw6,
and alopecia areata primarily with MHC Class II.
Despite these differences in HLA associations, both
diseases have in common a prominent role for CD8þ
lymphocytes. The purpose of this brief review is to
present the recent developments in the genetics of
psoriasis.
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Human leukocyte antigen (HLA) associations with psoriasis
have been recognized for 440 years (van der Steen et al.,
1992; Elder et al., 1994; Jackow et al, 1998; McDonagh and
Tazi-Ahnini, 2002), (Nair et al., 2006), (Gilhar et al., 2007),
(Elder et al., 2010; Gilhar et al., 2012), (Russell et al., 1972).
As would be expected given that CD8þ T cells recognize
antigens in the context of major histocompatibility complex
(MHC) Class I, MHC associations in psoriasis have consistent
map to the Class I region (Gudjonsson and Elder, 2012).
Cutaneous psoriasis is strongly associated with HLA-Cw6,
particularly in patients manifesting early onset, guttate
psoriasis, positive family history, and more severe disease
(Henseler and Christophers, 1985). In 2006, we reported a
detailed analysis of the MHC Class 1 region in 678 families,
which implicated HLA-C rather than corneodesmosin (Nair
et al., 2006). Besides HLA-Cw6, the HLA-Cw1-B46 haplotype
is strongly associated with psoriasis in southeast Asian
populations (Stuart et al., 2010b). Essentially, all previous
studies have found that psoriatic arthritis (PsA) is also
associated with HLA-Cw6, particularly with early onset of
skin disease (Gladman et al., 1999; Al-Heresh et al., 2002;
Ho et al., 2007). However, HLA-Cw6 is actually much less
frequent in PsA than in cutaneous psoriasis (Eder et al.,
2011; Winchester et al., 2011). HLA-B27 has also been
associated with PsA (Eder et al., 2011; Winchester et al.,
2011), but the strength of association is much lower than
in ankylosing spondylitis (Armstrong et al., 1983). Another
longstanding finding is the association of PsA with HLA-B38
and/or HLA-B39 (Eder et al., 2011), which have structural
homologies with HLA-B27 in the peptide-binding groove
(Bravo et al., 2003). HLA-B38/39 is more strongly associated
with polyarticular PsA, whereas HLA-B27 is more strongly
associated with axial PsA.
Only about 10% of HLA-Cw6 carriers develop psoriasis,
and it has been estimated that PSORS1 accounts for only one-
third of the heritability of psoriasis (Trembath et al., 1997).
In addition to PSORS1, earlier linkage studies reported 18
potential susceptibility loci (Sagoo et al., 2004; Karason et al.,
2005). However, most of these proved difficult to replicate
(Capon et al., 2004). After PSORS1, the second-most
consistently replicated psoriasis susceptibility locus from
pedigree studies is PSORS2 (17q24-q25) (Tomfohrde et al.,
1994). Two subsequent studies suggested a mutation at this
locus (Hwu et al., 2005; Yang et al., 2008), and the gene
involved has recently been identified as CARD14 on the basis
of both rare and common variants (Jordan et al., 2012a, b).
Additionally, two groups have recently identified the
interleukin 36RN (IL36RN) gene as the cause of a rare
recessive Mendelian form of pustular psoriasis (Marrakchi
et al., 2011; Onoufriadis et al., 2011).
Over the past 12 years, researchers studying complex
genetic disorders have turned to genome-wide association
studies to search for susceptibility loci, because association is
much more powerful than linkage in the search for common
susceptibility alleles (Risch and Merikangas, 1996).
This strategy has been very successful for psoriasis; by 2012,
at least 18 published non-MHC genetic loci met a stringent
(Po5 108) criterion for genome-wide significance in
Caucasians (Nair et al., 2009; Zhang et al., 2009; Ellinghaus
et al., 2010; Huffmeier et al., 2010; Strange et al., 2010; Stuart
et al., 2010a). Of these, four (IL12B, IL23A, IL23R, TRAF3IP2)
map within or near genes involved in the IL-23/T helper type
17 (Th17) axis (Cargill et al., 2007; Capon et al., 2008; Nair
et al., 2009; Zhang et al., 2009). Additional regions of
association contain genes whose products are involved in
the control of Th1/Th2 polarization (IL4/IL13)(Chang et al.,
2008; Nair et al., 2009), in regulating nuclear factor (NF)-kB
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and interferon signaling (TNFAIP3, TNIP1, NFKBIA, REL,
TYK2, and FBXL19) (Nair et al., 2009; Ellinghaus et al.,
2010; Sun et al., 2010; Stuart et al., 2010a), in MHC Class I
antigen processing (HLA-C, ERAP1, PSMA6) (Strange et al.,
2010; Sun et al., 2010), in inflammatory dendritic cell function
(NOS2) (Stuart et al., 2010a), and in epidermal barrier
formation (LCE3B/LCE3C) (de Cid et al., 2009; Zhang et al.,
2009). A report of increased defensin gene cluster copy
number in psoriasis (Hollox et al., 2008) is of interest, but
our subsequent efforts to replicate it in larger new cohorts
using improved methods for copy number determination met
with only modest success (Stuart et al., 2012). Five additional
loci (PTTG1, GJB2, CSMD1, ZNF816A, and SERPINB8)
achieve significance only in the Chinese population (Sun
et al., 2010).
We have recently completed a collaborative meta-analysis
of psoriasis (Tsoi et al., 2012). This international collabo-
ration engaged 420 different research consortia, who
contributed a total of 10,588 cases and 22,806 controls. In
addition to verifying all the Caucasian-origin loci described
above, we discovered 15 new disease susceptibility regions,
raising the number of loci associated with psoriasis in
Caucasians to 36. Using conditional analysis to look for
secondary signals, we found five independent hits within
previously known loci. We also confirmed epistatic (gene–
gene) interactions involving HLA-C and ERAP1 (Strange et al.,
2010), as well as HLA-C and LCE3B/3C (Zhang et al., 2009).
The newly identified regions shared with other autoimmune
diseases encompass a number of genes whose products
regulate T-cell function. The new psoriasis-specific regions
were notable for candidate genes involved in innate host
defense, encoding proteins with roles in interferon-mediated
antiviral responses, macrophage activation, and NF-kB
signaling. Besides emphasizing the importance of the skin
in innate host defense, the results also underscored strong
genetic similarities between psoriasis, ankylosing spondylitis,
Crohn’s disease, ulcerative colitis, and celiac disease
(Cotsapas et al., 2011), which have been observed at a
clinical level (Najarian and Gottlieb, 2003; Ludvigsson
et al., 2011; Jacques et al., 2012). Perhaps surprisingly,
given the prominent role of CD8þ lymphocytes in both
disorders, the genetic overlap between psoriasis and alopecia
areata was fairly limited. However, such assessments of
genetic overlap are constrained by the relative power of
different studies, and it will be interesting to revisit this
question as more powerful genetic analyses of both psoriasis
and alopecia areata emerge.
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